Pro-Dex, Inc. (PDEX) reports strong Q2 earnings and revenue, signaling positive growth in industry.

From Nasdaq: 2025-01-30 17:10:02

Pro-Dex, Inc. (PDEX) reported quarterly earnings of $0.61 per share, surpassing estimates and showing a significant increase from the previous year’s earnings of $0.14 per share. The company’s revenues also exceeded expectations, signaling positive growth in the medical-dental supplies industry.

Investors are eager to see how Pro-Dex, Inc. (PDEX) will perform in the near future, especially with mixed estimate revisions and a Zacks Rank #3 (Hold) currently in place. The company’s stock has seen fluctuations this year, but future earnings outlook and industry trends will play a crucial role in its performance.

In a related industry, West Pharmaceutical Services (WST) is expected to release its quarterly results soon, with projected earnings of $1.75 per share. Despite a slight decline in year-over-year earnings, the company’s revenues are expected to increase by 1% from the previous year.

If you’re considering investing in Pro-Dex, Inc. (PDEX) or other stocks, Zacks Investment Research offers valuable insights and recommendations to help guide your investment decisions. With a track record of providing independent research and stock ratings, Zacks can assist investors in making informed choices for their portfolios.



Read more at Nasdaq: Pro-Dex, Inc. (PDEX) Surpasses Q2 Earnings and Revenue Estimates